ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0238

Educational Experience and Engagement in the First Two Years of RheumMadness, an Online Community of Inquiry

Guy Katz1, Aki Garren2, Lauren He3, Ben Kellogg4, Michael Macklin5, Courtney Bair4, matthew Sparks4, Lisa Criscione-Schreiber4 and david leverenz4, 1Massachusetts General Hospital, Boston, MA, 2MedStar/Georgetown Washington Hospital Center, Silver Spring, MD, 3University of Chicago, Chicago, IL, 4Duke University School of Medicine, Durham, NC, 5University of Pittsburg Medical Center, Pittsburgh, PA

Meeting: ACR Convergence 2022

Keywords: education, medical, Work Force

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Professional Education Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: RheumMadness, an online educational initiative in which 16 rheumatology concepts compete as teams, completed its second season in 2022. In its first year, RheumMadness demonstrated success in engaging learners using the Community of Inquiry (CoI) framework, which evaluates cognitive, social, and teaching “presences.” After implementing changes to the tournament for its second year, we aimed to evaluate the educational experience of RheumMadness participants over its first two years.

Methods: RheumMadness consists of 16 rheumatology concepts that compete in a four-round single-elimination bracket. In 2021, the teams were based on specific manuscripts (e.g., clinical trials, guidelines) recently published in the rheumatology literature; in 2022, the teams were designed to represent broad rheumatology concepts with 1-2 base articles that provided an overview of those concepts. Scouting reports, describing the background and significance of each team and the projected chances of winning the tournament, were written largely by trainees ( >40 in 2021 and >60 in 2022). Participants in the tournament submitted brackets of predicted outcomes, and winners of each round were decided by a 7-member Blue Ribbon Panel (BRP) of rheumatologists. In 2022, an email newsletter was established in an attempt to increase participation outside of social media (SoMe). Participants completed surveys assessing RheumMadness engagement and learning experience using questions adapted from a validated CoI survey. Likert scores ranging from 1 (“strongly disagree”) to 5 (“strongly agree”) were used. Comparisons between 2021 and 2022 were done via unpaired T tests.

Results: Engagement in RheumMadness 2021 and 2022 is summarized in Table 1. In 2022, there were more brackets submitted (121 vs. 100). While there were fewer podcast episodes in 2022, there were more downloads per episode (245 vs. 163) in 2022. On Twitter, there were similar numbers of posts (556 vs 570), but engagements (likes, retweets, replies) were slightly lower in 2022 (1,930 vs. 2,392). Among participants who completed post-tournament surveys, characteristics and engagement were similar between the two years (Table 2). There was high engagement in all CoI presences, with mean Likert scores ranging from 3.5 to 4.5; there were no significant differences between the two years (Figure 1).

Conclusion: RheumMadness engagement and educational experience were high in the first two years of the tournament. There was a small reduction in engagements with posts on SoMe in 2022, though learners also had the ability to engage with RheumMadness through the introduction of a newsletter. Broadening the scope of topics reviewed in the tournament had no net impact on the CoI presences with which participants engaged.

Supporting image 1

Table 1. Direct metrics of engagement with RheumMadness, 2021 and 2022. *Twitter engagements included interactions with tweets such as likes, retweets, and replies.

Supporting image 2

Table 2. Participant characteristics and engagement, 2021 vs 2022. All values reported as n (%) unless noted otherwise. APP: Advanced practice provider.

Supporting image 3

Figure 1. Participant educational experience using the Community of Inquiry framework, 2021 vs 2022. All comparisons between 2021 and 2022 are not statistically significant.


Disclosures: G. Katz, None; A. Garren, None; L. He, None; B. Kellogg, None; M. Macklin, None; C. Bair, None; m. Sparks, Renal Research Institute, American Board of Internal Medicine, NephJC, American Journal of Kidney Diseases, Kidney360, Kidney Medicine, ASN Kidney News, KCVD Membership & Communications Committee- AHA, Elsevier- Nephrology Secrets, KCVD Scientific & Clinical Education Lifelong Learning Committee (SCILL)- AHA, NKF North Carolina; L. Criscione-Schreiber, GlaxoSmithKlein(GSK); d. leverenz, Pfizer, Rheumatology Research Fund.

To cite this abstract in AMA style:

Katz G, Garren A, He L, Kellogg B, Macklin M, Bair C, Sparks m, Criscione-Schreiber L, leverenz d. Educational Experience and Engagement in the First Two Years of RheumMadness, an Online Community of Inquiry [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/educational-experience-and-engagement-in-the-first-two-years-of-rheummadness-an-online-community-of-inquiry/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/educational-experience-and-engagement-in-the-first-two-years-of-rheummadness-an-online-community-of-inquiry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology